Oral hypoglycemic agents (OHAs) are a group of drugs used to help reduce the amount of sugar present in the blood. They are not insulin, but they stimulate the pancreas to produce insulin.
At present, China is a country with the most populous victims of diabetes, SO, China will witness a huge potential in the OHAS market.
The global Oral Hypoglyceimic Agents (OHAs) market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Oral Hypoglyceimic Agents (OHAs) volume and value at global level, regional level and company level. From a global perspective, this report represents overall Oral Hypoglyceimic Agents (OHAs) market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Oral Hypoglyceimic Agents (OHAs) in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Oral Hypoglyceimic Agents (OHAs) manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Pfizer
GlaxoSmithKline
Bayer
Bristol-Myers Squibb
Novonordisk
Sanofi-Aventis
Servier
Huadong Medicine
Wanbang Biopharmaceuticals
Double-Crane Pharmaceutical
Guangzhou Pharmaceutical
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Sulfonylureas
Metformin
Thiazolidinediones
Alpha-Glucosidase Inhibitors
Segment by Application
Hospitals and Clinics
Others
Table of Contents
Report Introduction
1 Industry Overview of Oral Hypoglyceimic Agents (OHAs)
1.1 Definition of Oral Hypoglyceimic Agents (OHAs)
1.2 Oral Hypoglyceimic Agents (OHAs) Segment by Type
1.2.1 Global Oral Hypoglyceimic Agents (OHAs) Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Sulfonylureas
1.2.3 Metformin
1.2.4 Thiazolidinediones
1.2.5 Alpha-Glucosidase Inhibitors
1.3 Oral Hypoglyceimic Agents (OHAs) Segment by Applications
1.3.1 Global Oral Hypoglyceimic Agents (OHAs) Consumption Comparison by Applications (2014-2025)
1.3.2 Hospitals and Clinics
1.3.3 Others
1.4 Global Oral Hypoglyceimic Agents (OHAs) Overall Market
1.4.1 Global Oral Hypoglyceimic Agents (OHAs) Revenue (2014-2025)
1.4.2 Global Oral Hypoglyceimic Agents (OHAs) Production (2014-2025)
1.4.3 North America Oral Hypoglyceimic Agents (OHAs) Status and Prospect (2014-2025)
1.4.4 Europe Oral Hypoglyceimic Agents (OHAs) Status and Prospect (2014-2025)
1.4.5 China Oral Hypoglyceimic Agents (OHAs) Status and Prospect (2014-2025)
1.4.6 Japan Oral Hypoglyceimic Agents (OHAs) Status and Prospect (2014-2025)
1.4.7 Southeast Asia Oral Hypoglyceimic Agents (OHAs) Status and Prospect (2014-2025)
1.4.8 India Oral Hypoglyceimic Agents (OHAs) Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Oral Hypoglyceimic Agents (OHAs)
2.3 Manufacturing Process Analysis of Oral Hypoglyceimic Agents (OHAs)
2.4 Industry Chain Structure of Oral Hypoglyceimic Agents (OHAs)
3 Development and Manufacturing Plants Analysis of Oral Hypoglyceimic Agents (OHAs)
3.1 Capacity and Commercial Production Date
3.2 Global Oral Hypoglyceimic Agents (OHAs) Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Oral Hypoglyceimic Agents (OHAs)
3.4 Recent Company Developments and Expansion Plans
4 Key Figures of Major Manufacturers
4.1 Oral Hypoglyceimic Agents (OHAs) Production and Capacity Analysis
4.2 Oral Hypoglyceimic Agents (OHAs) Revenue Analysis
4.3 Oral Hypoglyceimic Agents (OHAs) Price Analysis
4.4 Market Concentration Degree
5 Oral Hypoglyceimic Agents (OHAs) Regional Market Analysis
5.1 Oral Hypoglyceimic Agents (OHAs) Production by Regions
5.1.1 Global Oral Hypoglyceimic Agents (OHAs) Production by Regions
5.1.2 Global Oral Hypoglyceimic Agents (OHAs) Revenue by Regions
5.2 Oral Hypoglyceimic Agents (OHAs) Consumption by Regions
5.3 North America Oral Hypoglyceimic Agents (OHAs) Market Analysis
5.3.1 North America Oral Hypoglyceimic Agents (OHAs) Production
5.3.2 North America Oral Hypoglyceimic Agents (OHAs) Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Oral Hypoglyceimic Agents (OHAs) Import and Export
5.4 Europe Oral Hypoglyceimic Agents (OHAs) Market Analysis
5.4.1 Europe Oral Hypoglyceimic Agents (OHAs) Production
5.4.2 Europe Oral Hypoglyceimic Agents (OHAs) Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Oral Hypoglyceimic Agents (OHAs) Import and Export
5.5 China Oral Hypoglyceimic Agents (OHAs) Market Analysis
5.5.1 China Oral Hypoglyceimic Agents (OHAs) Production
5.5.2 China Oral Hypoglyceimic Agents (OHAs) Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Oral Hypoglyceimic Agents (OHAs) Import and Export
5.6 Japan Oral Hypoglyceimic Agents (OHAs) Market Analysis
5.6.1 Japan Oral Hypoglyceimic Agents (OHAs) Production
5.6.2 Japan Oral Hypoglyceimic Agents (OHAs) Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Oral Hypoglyceimic Agents (OHAs) Import and Export
5.7 Southeast Asia Oral Hypoglyceimic Agents (OHAs) Market Analysis
5.7.1 Southeast Asia Oral Hypoglyceimic Agents (OHAs) Production
5.7.2 Southeast Asia Oral Hypoglyceimic Agents (OHAs) Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Oral Hypoglyceimic Agents (OHAs) Import and Export
5.8 India Oral Hypoglyceimic Agents (OHAs) Market Analysis
5.8.1 India Oral Hypoglyceimic Agents (OHAs) Production
5.8.2 India Oral Hypoglyceimic Agents (OHAs) Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Oral Hypoglyceimic Agents (OHAs) Import and Export
6 Oral Hypoglyceimic Agents (OHAs) Segment Market Analysis (by Type)
6.1 Global Oral Hypoglyceimic Agents (OHAs) Production by Type
6.2 Global Oral Hypoglyceimic Agents (OHAs) Revenue by Type
6.3 Oral Hypoglyceimic Agents (OHAs) Price by Type
7 Oral Hypoglyceimic Agents (OHAs) Segment Market Analysis (by Application)
7.1 Global Oral Hypoglyceimic Agents (OHAs) Consumption by Application
7.2 Global Oral Hypoglyceimic Agents (OHAs) Consumption Market Share by Application (2014-2019)
8 Oral Hypoglyceimic Agents (OHAs) Major Manufacturers Analysis
8.1 Pfizer
8.1.1 Pfizer Oral Hypoglyceimic Agents (OHAs) Production Sites and Area Served
8.1.2 Pfizer Report Overview, Application and Specification
8.1.3 Pfizer Oral Hypoglyceimic Agents (OHAs) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 GlaxoSmithKline
8.2.1 GlaxoSmithKline Oral Hypoglyceimic Agents (OHAs) Production Sites and Area Served
8.2.2 GlaxoSmithKline Report Overview, Application and Specification
8.2.3 GlaxoSmithKline Oral Hypoglyceimic Agents (OHAs) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Bayer
8.3.1 Bayer Oral Hypoglyceimic Agents (OHAs) Production Sites and Area Served
8.3.2 Bayer Report Overview, Application and Specification
8.3.3 Bayer Oral Hypoglyceimic Agents (OHAs) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Bristol-Myers Squibb
8.4.1 Bristol-Myers Squibb Oral Hypoglyceimic Agents (OHAs) Production Sites and Area Served
8.4.2 Bristol-Myers Squibb Report Overview, Application and Specification
8.4.3 Bristol-Myers Squibb Oral Hypoglyceimic Agents (OHAs) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Novonordisk
8.5.1 Novonordisk Oral Hypoglyceimic Agents (OHAs) Production Sites and Area Served
8.5.2 Novonordisk Report Overview, Application and Specification
8.5.3 Novonordisk Oral Hypoglyceimic Agents (OHAs) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Sanofi-Aventis
8.6.1 Sanofi-Aventis Oral Hypoglyceimic Agents (OHAs) Production Sites and Area Served
8.6.2 Sanofi-Aventis Report Overview, Application and Specification
8.6.3 Sanofi-Aventis Oral Hypoglyceimic Agents (OHAs) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Servier
8.7.1 Servier Oral Hypoglyceimic Agents (OHAs) Production Sites and Area Served
8.7.2 Servier Report Overview, Application and Specification
8.7.3 Servier Oral Hypoglyceimic Agents (OHAs) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Huadong Medicine
8.8.1 Huadong Medicine Oral Hypoglyceimic Agents (OHAs) Production Sites and Area Served
8.8.2 Huadong Medicine Report Overview, Application and Specification
8.8.3 Huadong Medicine Oral Hypoglyceimic Agents (OHAs) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 Wanbang Biopharmaceuticals
8.9.1 Wanbang Biopharmaceuticals Oral Hypoglyceimic Agents (OHAs) Production Sites and Area Served
8.9.2 Wanbang Biopharmaceuticals Report Overview, Application and Specification
8.9.3 Wanbang Biopharmaceuticals Oral Hypoglyceimic Agents (OHAs) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 Double-Crane Pharmaceutical
8.10.1 Double-Crane Pharmaceutical Oral Hypoglyceimic Agents (OHAs) Production Sites and Area Served
8.10.2 Double-Crane Pharmaceutical Report Overview, Application and Specification
8.10.3 Double-Crane Pharmaceutical Oral Hypoglyceimic Agents (OHAs) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served
8.11 Guangzhou Pharmaceutical
9 Development Trend of Analysis of Oral Hypoglyceimic Agents (OHAs) Market
9.1 Global Oral Hypoglyceimic Agents (OHAs) Market Trend Analysis
9.1.1 Global Oral Hypoglyceimic Agents (OHAs) Market Size (Volume and Value) Forecast 2019-2025
9.2 Oral Hypoglyceimic Agents (OHAs) Regional Market Trend
9.2.1 North America Oral Hypoglyceimic Agents (OHAs) Forecast 2019-2025
9.2.2 Europe Oral Hypoglyceimic Agents (OHAs) Forecast 2019-2025
9.2.3 China Oral Hypoglyceimic Agents (OHAs) Forecast 2019-2025
9.2.4 Japan Oral Hypoglyceimic Agents (OHAs) Forecast 2019-2025
9.2.5 Southeast Asia Oral Hypoglyceimic Agents (OHAs) Forecast 2019-2025
9.2.6 India Oral Hypoglyceimic Agents (OHAs) Forecast 2019-2025
9.3 Oral Hypoglyceimic Agents (OHAs) Market Trend (Product Type)
9.4 Oral Hypoglyceimic Agents (OHAs) Market Trend (Application)
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Oral Hypoglyceimic Agents (OHAs) Customers
11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors
12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer
We employs a three way data triangulation approach to arrive at market estimates. We use primary research, secondary research and data triangulation by top down and bottom up approach
Secondary Research:
Our research methodology involves in-depth desk research using various secondary sources. Data is gathered from association/government publications/databases, company websites, press releases, annual reports/presentations/sec filings, technical papers, journals, research papers, magazines, conferences, tradeshows, and blogs.
Key Data Points through secondary research-
Macro-economic data points
Import Export data
Identification of major market trends across various applications
Primary understanding of the industry for both the regions
Competitors analysis for the production capacities, key production sites, competitive landscape
Key customers
Production Capacity
Pricing Scenario
Cost Margin Analysis
Key Data Points through primary research-
Major factors driving the market and its end application markets
Comparative analysis and customer analysis
Regional presence
Collaborations or tie-ups
Annual Production, and sales
Profit Margins
Average Selling Price
Data Triangulation:
Data triangulation is done using top down and bottom approaches. However, to develop accurate market sizing estimations, both the methodologies are used to accurately arrive at the market size. Insert Image